SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-17-048378
Filing Date
2017-09-18
Accepted
2017-09-18 06:20:08
Documents
1
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v475339_4a.html 4/A  
1 OWNERSHIP DOCUMENT v475339_4a.xml 4/A 4371
  Complete submission text file 0001144204-17-048378.txt   5861
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address
Wu Yue Alexander (Reporting) CIK: 0001682419 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36150 | Film No.: 171088949